Mukka Proteins Ltd

At Rs 26.87, sellers were still queuing — but there were no buyers willing to take the other side. Mukka Proteins Ltd locked at its lower circuit of 3.61% on 18 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock.

Mukka Proteins Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, reflecting a renewed investor interest amid a mixed performance backdrop. The company’s price-to-earnings (P/E) ratio now stands at 12.23, signalling improved price attractiveness relative to its historical and peer averages within the FMCG sector.

At Rs 28.06, sellers were still queuing — but there were no buyers willing to take the other side. Mukka Proteins Ltd locked at its lower circuit of 2.64% on 17 Sep 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

Mukka Proteins Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

With a decisive break above Rs 33.24 on 7 Sep 2026, Mukka Proteins Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week.

Mukka Proteins Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a growing investor confidence amid robust price momentum and improving financial metrics. This micro-cap FMCG player’s recent performance and valuation changes warrant a closer examination against its historical averages and peer group benchmarks.

Mukka Proteins Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 September 2026, providing investors with the latest insights into the company’s performance and outlook.

Surging past its previous peaks, Mukka Proteins Ltd touched a fresh 52-week high of Rs 31.5 on 4 Sep 2026, propelled by a confluence of bullish technical indicators and sustained price momentum.

Mukka Proteins Ltd has demonstrated a notable shift in technical momentum, upgrading its outlook from mildly bullish to bullish as of early September 2026. This change is underpinned by a confluence of positive signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting renewed investor confidence in this micro-cap FMCG stock.

Mukka Proteins Ltd, a micro-cap player in the FMCG sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend. This change is underscored by a strong daily price surge of 7.97% to ₹26.68, reflecting renewed investor interest despite mixed signals from key technical indicators and broader market comparisons.

Mukka Proteins Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Mukka Proteins Ltd has demonstrated a marked shift in price momentum, upgrading its technical outlook from mildly bullish to bullish. This change is underpinned by positive signals from key technical indicators including MACD, moving averages, and Bollinger Bands, signalling renewed investor interest in the micro-cap FMCG player.

The 50-day moving average for Mukka Proteins Ltd has crossed above the 200-day moving average, signalling a golden cross on 17 Jun 2026. Yet, the broader technical and fundamental picture presents a nuanced view, with some indicators supporting the crossover while others remain inconclusive or contradictory.

Mukka Proteins Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Sell to Hold as of 13 August 2026, reflecting significant improvements across financial performance, technical indicators, and valuation metrics. The company’s recent quarterly results and evolving market trends have prompted analysts to revise their outlook, signalling cautious optimism for investors.